跳至主要内容
临床试验/NCT05621564
NCT05621564招募中不适用

The Effect of Pre-operative Therapy on Response and Survival in Breast Cancer

RenJi Hospital1 个研究点 分布在 1 个国家目标入组 6,032 人开始时间: 2022年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
6,032
试验地点
1
主要终点
Pathologic Complete Response

研究概览

简要总结

This is a prospective and retrospective study to evaluate the effect of pre-operative therapy on response and survival, and compare the difference in response and survival by pre-operative regimen or by patient's clinicopathological characteristic in early or advanced breast cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female, Aged ≥18 years
  • Histologically confirmed primary breast cancer
  • Plan to receive pre-operative therapy
  • Adequate organ function

排除标准

  • History of neurological or psychological disease, including epilepsy or dementia
  • Not suitable to participate in this study judged by investigators

研究组 & 干预措施

advanced breast cancer

no requirements for therapy

干预措施: pre-operative therapy (Drug)

early breast cancer

no requirements for therapy

干预措施: pre-operative therapy (Drug)

结局指标

主要结局

Pathologic Complete Response

时间窗: at surgery

ypT0 ypN0, ypT0/is ypN0

次要结局

  • Disease-free Survival(From surgery until time of event up to 8 years)
  • Objective response rate(from the start of pre-operative treatment until the completion of surgery up to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wenjin Yin

Deputy Chief of Breast Surgery Department

RenJi Hospital

研究点 (1)

Loading locations...

相似试验